awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30577671-F2B627B5-303C-4EA4-BEE9-7D8632154965
Q30577671-F2B627B5-303C-4EA4-BEE9-7D8632154965
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30577671-F2B627B5-303C-4EA4-BEE9-7D8632154965
Safety results from a pooled analysis of randomized, controlled phase II and III clinical trials and interim data from an open-label extension trial of the interleukin-12/23 monoclonal antibody, briakinumab, in moderate to severe psoriasis.
P2860
Q30577671-F2B627B5-303C-4EA4-BEE9-7D8632154965
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30577671-F2B627B5-303C-4EA4-BEE9-7D8632154965
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
886006d159651c1a496ceebac7d23ed3281198a7
P2860
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)